Medical devices

Information

  • Patent Grant
  • 10639002
  • Patent Number
    10,639,002
  • Date Filed
    Tuesday, June 11, 2013
    10 years ago
  • Date Issued
    Tuesday, May 5, 2020
    4 years ago
Abstract
An embryo transfer catheter or other medical device has a shaft extruded with two layers. The outer layer is relatively thick and contains gas bubbles sufficient to increase the visibility of the catheter under ultrasound observation but with a density that allows material within the catheter to be viewed by the eye. The inner layer is relatively thin and is free of bubbles so that it provides a smooth bore to the catheter.
Description
BACKGROUND OF THE INVENTION

This invention relates to medical devices.


The invention is more particularly concerned with catheters or the like, that are visible under ultrasound observation.


Ultrasound imaging equipment is increasingly being used during surgical procedures to monitor the location of a device within the body. The visibility of a device under ultrasound depends on various factors including the difference between the acoustic impedance of the material of the device and that of the surrounding medium, such as the patient tissue or body fluid w thin which the device is located. This difference is relatively low with plastic devices such as catheters and may make conventional catheters difficult to locate. Even devices of metal, such as needles, present problems of visibility under ultrasound observation because of the directional nature of the reflections. In some orientations a metal needle may be clearly visible but in other orientations it may be considerably less visible.


Attempts have been made to increase the visibility of medico-surgical devices under ultrasound observation in various ways. The surface of the device may be modified, such as by forming grooves or indentations in its surface. A reflective coating may be applied to the device, such as incorporating bubbles, as described in WO98/19713 and EP0624342. Alternatively, a metal marker may be secured to a plastics catheter. GB2379610 describes a catheter where the wall is made entirely of a plastics including gas bubbles or where bubble-containing material is in a stripe occupying only a part of the circumference. Although this latter form of catheter has various advantages, it has been found that there is a tendency for the surface of the bore through the catheter to be interrupted by small protrusions where the bubbles break the surface. In some applications, such as for embryo transfer, It is important that the bore of the catheter is as smooth as possible so any interruption of this is a disadvantage. In other applications it may be important instead for the outer surface to be as smooth as possible, or for both the outer and inner surface to be smooth.


BRIEF SUMMARY OF THE INVENTION

It is an object of the present invention to provide an alternative medical device.


According the present invention there is provided a medical device having an elongate portion of plastics material, the portion being extruded with at least a first, inner layer and a second layer on the outside of the inner layer one of the layers being substantially free of gas bubbles and the other of the layers including gas bubbles dispersed within it to increase the visibility of the device under ultrasound imaging.


The layer substantially free of gas bubbles may be thinner than the other layer. The layer substantially free of gas bubbles may be the inner layer. The second layer may provide an outer surface of the catheter. The device may include a third layer on the outside of the second layer. The second layer may contain gas bubbles and the first and third layers may be substantially free of gas bubbles. The bubbles may be in a region extending around the entire circumference of the device. The bubbles preferably extend in a continuous region along the length of the device. The gas bubbles may have a size in the range 0.1μ to 300μ, preferably having a size in the range 1μ to 50μ and roost preferably having a size in the range 5μ to 10μ. The gas bubbles may be provided by gas-filled polymer microspheres. The device may be a catheter having a bore extending along its length. The inner layer may have an inner surface providing the bore of the catheter. The plastics material is preferably transparent to the eye, the density of bubbles being such as to permit material within the catheter to be viewed by the eye.


An embryo-transfer catheter and its method of manufacture, according to the present invention, will now be described, by way of example, with reference to the accompanying drawing.





BRIEF DESCRIPTION OF THE DRAWING


FIG. 1 is a side elevation view of the catheter;



FIG. 2 is a sectional side elevation view of the catheter of FIG. 1 to a larger scale;



FIG. 3 is a cross-section view of the catheter along the line III-III of FIG. 2;



FIG. 4 illustrates schematically manufacture of the catheter;



FIG. 5 is a sectional side elevation view of a part of an alternative catheter; and



FIG. 6 is a cross-section view of the catheter of FIG. 5 along the line VI-VI.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

With reference first to FIGS. 1 to 3, the catheter comprises art elongate portion in the form of a flexible shaft 1 and a hub 2 joined at the rear end of the shaft. The shaft 1 has a circular section and a bore 10 extending along its length. The shaft 1 opens at its forward, right-hand, patient end 11, which is atraumatically rounded.


The shaft 1 is extruded in two layers 12 and 13. The first, inner layer 12 is of a clear, transparent polyurethane material and is free of gas bubbles so that its inner surface 14, providing the surface of the bore 10, is completely smooth. The second layer 13 is formed around the entire circumference of the first layer 12 and its outer surface 15 provides the outer surface of the catheter. The second layer 13 incorporates small, gas-filled bubbles 22 the size and distribution of which are selected to increase the visibility of the catheter under ultrasound observation. Typically, the gas bubbles have a diameter in the range of about 0.1μ to 300μ, preferably being between 1μ and 50μ with the most preferred range being about 5μ to 10μ. The bubbles 22 extend uniformly through the thickness and around the circumference of the second layer 13 and may be spherical or of any other regular or irregular shape. The second layer 13 is preferably made from the same plastics material as the first layer and the gas bubbles are preferably provided by incorporating gas-filled polymer microspheres such as of the kind sold under the trade mark Expancel (“Expancel” is a registered trade mark of Akzo Nobel). The bubble-filled layer 13 is preferably as thick as possible so as to increase the visibility of the catheter under ultrasound observation. The inner layer 12 may be relatively in since its purpose is solely to provide a smooth inner surface for the catheter.


The hub 2 serves to make connection with the shaft 1 and is moulded from a rigid, transparent plastics material, being subsequently bonded with the rear end of the shaft.

    • The shaft 1 is extruded in the manner shown in FIG. 4 using an extrusion machine 20. The machine 20 has two extrusion heads 21 and 19, winch are supplied respectively with a polyurethane material 23 and with a polyurethane material 24 containing hollow microspheres. The two materials 23 and 24 are heated and supplied to the respective extrusion heads 21 and 19 so that tubing is formed with the bubble-filled material 24 coextruded as the outer layer 13 about the outside of the inner layer 12, which is of the bubble-free material 23. The shaft 1 can be extruded continuously at low cost, without the need for any subsequent operations apart from attaching the hub 2 and end forming the patient end tip 11.


The bubbles could be formed in various other ways, such as by injecting gas into the melt. Alternatively, chemical foaming agents could be added to the plastics material, such as: azocarbonomides, dinitrosopentmethelyene-tetramine, benzenephonohydrazine, 4,4 oxybis(benzenephonohydrazine), NN1dimethyl-NN1 dinitrosoterephthalamide, azoisobutyronitrile, sodium bicarbonate, terephthalazide or trihydrazinatrazine. Another way of forming the gas bubbles would be by incorporating a liquid into the plastics melt which volatises during the melt process. Alternatively, solid powdered dry ice (carbon dioxide) could be incorporated into the melt so that the particles of dry ice become gas bubbles during the forming process. It might be possible to use other solids which undergo sublimation in this way. The bubbles could be formed directly as a result of chemical reaction during polymerisation and or alternatively during cross-linking. The bubbles could be formed mechanically by whipping the plastics in a liquid form, such as in the manner used to form latex foam. Alternatively, small particles of a soluble material could be added to the plastics melt and subsequently dissolved away.

    • The bubble-filled layer need not provide the outer surface of the catheter, especially where the outer surface of the catheter needs to be smoother than can be provided by a bubble layer with bubbles 122. Instead, as shown in FIGS. 5 and 6, the bubble-filled layer 113 could be sandwiched between an inner layer 112 and a third, outer layer 116, the inner and outer layers being of the same material and being free of bubbles. Preferably, the inner layer 112 and the outer layer 116 are relatively thin and the middle, bubble-filled layer 113 is relatively thick, to maximise the ultrasound reflecting properties of the catheter. This three-layer tube is also made by co-extruding the three layers with one another. Alternatively, where it was necessary for the outer surface of the catheter to be smooth and there was no need for the bore to be smooth, the catheter could just have two layers where the outer layer was thin and bubble-free and the inner layer was thicker and contained bubbles.


The catheter could have any number of additional layers with one or more layers containing bubbles.


Catheters according to the present invention can be made having good visibility under ultrasound imaging without producing multiple echoes. They can produce a good image regardless of the orientation of the catheter shaft. The shaft can be made sufficiently transparent to ultrasound energy to enable material flowing along the bore of the catheter to be observed on the ultrasound image.


Because the catheter does not require any coating or separate marker there is no need for subsequent assembly operations and there is no risk of detachment. The catheter can be made of conventional, medically-approved materials so does not present any new risk to the patient. The outer surface of the three-layer catheter can be smooth so the catheter can be inserted or slid through an outer tube with low friction. A smooth bore can be provided to a catheter to ensure free flow along the bore, which can be important where the catheter is used to transfer embryos. In other applications, a smooth inner surface may reduce the accumulation of biofilm in the catheter. The catheter can be made without the need for metal components, which can be an advantage where the catheter is used while the patient is being viewed by magnetic imaging techniques. The catheter can be completely transparent to x-rays or the plastics from which it is formed could incorporate an x-ray opaque filler, such as barium sulphate.


The bubble size and density can be selected so that the optical transparency of the plastics forming the shaft remains sufficient to enable material flowing along the shaft to be viewed by the eye.


It is not essential for the bubbles to be provided around the entire circumference of the bubble-containing layer, instead, the bubbles could just be provided along a longitudinal stripe in the layer. This arrangement can be used where the shaft needs to have increased clarity so that material within the catheter can be seen by the eye. Alternatively, the bubbles could be contained around the entire circumference of the layer apart from a bubble-free longitudinal strip. The bubble region need not be continuous along the length of the catheter. Instead, discrete separate regions with bubbles could be separated from one another along the length of the catheter by regions without bubbles. A shaft for such a catheter could be made by blowing gas into the plastics forming the bubble layer and by interrupting the gas flow. Where the bubbles are contained within a stripe, this could be interrupted to make it discontinuous by extruding the stripe using two auxiliary extruders, one having material with hollow microspheres and the other having material without the microspheres. Alternate extruders would be switched on and off so that the stripe could have sections containing bubbles separated from one another by sections without bubbles. A catheter having a layer with an interrupted bubble region may give a clearer ultrasound indication of movement of the catheter along its length and may also enable clearer observation of material flowing along the catheter both by ultrasound and by the eye.


The invention is not confined to catheters but could be used in other medical devices such as cables and medical devices without a bore, or with more than one bore.

Claims
  • 1. A surgical procedure comprising: placing a medical device within a patient, the medical device having an elongate portion of a first layer of a first polymeric material and a second layer of a second polymeric material formed around the first layer, the first and second layers being coextruded from the first and second polymeric materials, respectively, the second polymeric material being the same as the first polymeric material, the first layer being extruded to be substantially free of gas bubbles and forming an innermost layer of the elongate portion of the medical device, and the second layer being extruded to include gas bubbles dispersed in its polymeric material and forming an outermost layer of the elongate portion of the medical device, and the first layer that is substantially free of gas bubbles being thinner than the second layer that includes the gas bubbles such that the second layer forms a main substrate of the elongate portion of the medical device; andusing ultrasound imaging equipment to monitor a location of the medical device within the patient, the location of the medical device within the patient being readily observable by the ultrasound equipment due to the second layer of the medical device that includes gas bubbles providing increased visibility of the medical device under ultrasound imaging.
  • 2. The procedure of claim 1, wherein the elongate portion is a catheter having a bore defined by an inner wall of the first layer.
  • 3. The procedure of claim 2, wherein the elongate portion is an embryo transfer catheter, and the first and second polymeric materials are sufficiently transparent to ultrasound energy to enable an embryo moving within a lumen of the catheter to be monitored by the ultrasound imaging equipment.
  • 4. A method of manufacturing a medical device usable for ultrasound imaging, the method comprising the steps of: supplying a first polymeric material to an extrusion machine;supplying a second polymeric material to the extrusion machine, the second polymeric material being the same as the first polymeric material;coextruding the first and second polymeric materials with one another to form an elongate tubing with a first layer of the first polymeric material forming an inner wall of the tubing to define a bore of the tubing and a second layer of the second polymeric material formed around the first layer to form an outermost surface of the tubing of the medical device;wherein the first layer of polymeric material is substantially free of gas bubbles and the second layer of polymeric material includes gas bubbles dispersed within its polymeric material to increase the visibility of the medical device under ultrasound imaging; andwherein the first layer that is substantially free of gas bubbles is thinner than the second layer that includes the gas bubbles such that the second layer forms a main substrate of the elongate tubing of the medical device.
  • 5. The method of claim 4, further comprising the step of: providing gas-filled polymer microspheres to the second polymeric material to form the gas bubbles, wherein the gas bubbles have a size in the range 0.1μ to 300μ.
  • 6. The method of claim 4, wherein the coextruding step comprises extruding the second layer of the tubing to be thicker than the first layer.
  • 7. The method of claim 4, wherein the medical device is a catheter and the elongate tubing of the catheter has first and second ends, the method further comprising the steps of: adding a hub to one of the first and second ends of the catheter; androunding the other of the first and second ends to prevent trauma to the patient when the catheter is inserted into the patient.
  • 8. A method of monitoring the location of a medical device within a patient, comprising: placing within the patient a medical device having an elongate portion with a first layer of a first polymeric material and a second layer of a second polymeric material coextruded with one another so that second layer is formed around the first layer, the second polymeric material being the same as the first polymeric material, the first layer being substantially free of gas bubbles and forming an innermost layer of the elongate portion of the medical device, and the second layer including gas bubbles dispersed in its polymeric material to increase the visibility of the elongate portion under ultrasound imaging and forming an outermost layer of the elongate portion of the medical device, and the first layer that is substantially free of gas bubbles being thinner than the second layer that includes the gas bubbles such that the second layer forms a main substrate of the elongate portion of the medical device; andusing ultrasound imaging equipment to monitor the location of the medical device within the patient.
  • 9. A method of manufacturing an embryo transfer catheter adapted to be viewed under ultrasound imaging, the method comprising: supplying a first polymeric material to an extrusion machine;supplying a second polymeric material to the extrusion machine, the second polymeric material being the same as the first polymeric material;coextruding the first and second polymeric materials with one another to form an elongate tubing of the embryo transfer catheter, the elongate tubing consisting of a first layer of the first polymeric material forming an inner wall of the tubing to define a bore of the tubing and a second layer of the second polymeric material formed around the first layer and forming an outermost surface of the tubing of the embryo transfer catheter;wherein the first layer is extruded to be substantially free of gas bubbles and the second layer is extruded to include gas bubbles dispersed in its polymeric material, wherein the first layer that is substantially free of gas bubbles is thinner than the second layer that includes the gas bubbles such that the second layer forms a main substrate of the embryo transfer catheter, and wherein the visibility of the embryo transfer catheter under ultrasound imaging is increased due to the gas bubbles dispersed in the polymeric material of the second layer.
  • 10. The method of claim 9, further comprising the step of: selecting a size and density of the gas bubbles so that the optical transparency of the polymeric materials is sufficiently transparent to enable an embryo moving within the bore of the elongate tubing to be viewed by eye.
  • 11. The method of claim 10, further comprising the step of: selecting the size of the gas bubbles to be in the range of 0.1μ to 300μ.
  • 12. The method of claim 9, further comprising the step of: selecting the size of the bubbles to be in the range of 1μ to 50μ.
  • 13. The method of claim 9, wherein the coextruding step further comprises: coextruding the first layer that is substantially free of gas bubbles to form a smooth surface for the inner wall that defines the bore of the elongate tubing to reduce trauma to embryos moving through the elongate tubing.
  • 14. A method of manufacturing a medical device viewable under ultrasound imaging, the method comprising the steps of: supplying a first polymeric material to an extrusion machine for extrusion as a first layer substantially free of gas bubbles;supplying a second polymeric material to the extrusion machine for extrusion as a second layer including gas bubbles, the second polymeric material being the same as the first polymeric material;coextruding the first and second polymeric materials with one another to form an elongate tubing consisting of the first and second layers, the first layer forming an inner wall of the elongate tubing to define a bore of the elongate tubing and the second layer formed around the first layer and forming an outermost surface of the elongate tubing of the medical device, wherein the first layer that is substantially free of gas bubbles is thinner than the second layer that includes the gas bubbles such that the second layer forms a main substrate of the elongate tubing of the medical device;wherein visibility of the medical device under ultrasound imaging is increased due to the medical device having the second layer that includes gas bubbles, and wherein the first and second polymeric materials are sufficiently transparent to ultrasound energy to enable material moving within the bore of the elongate tubing to be visualized under ultrasound imaging.
  • 15. The method of claim 14, further comprising the step of: selecting a size of the bubbles to be in the range 0.1μ to 300μ.
  • 16. The method of claim 14, further comprising the step of: selecting a size of the bubbles to be in the range of 1μ to 50μ.
  • 17. The method of claim 14, further comprising the step of: selecting a size of the bubbles to be in the range of 5μ to 10μ.
Priority Claims (1)
Number Date Country Kind
0307350.9 Mar 2003 GB national
US Referenced Citations (278)
Number Name Date Kind
2702034 Walter Feb 1955 A
2740192 Ogle Apr 1956 A
2989053 Hamilton Jun 1961 A
3093134 Roehr Jun 1963 A
3605750 Sheridan et al. Sep 1971 A
3720210 Diettrich Mar 1973 A
4265251 Tickner May 1981 A
4386628 Stanley Jun 1983 A
4582061 Fry Apr 1986 A
4644977 Arterburn Feb 1987 A
4701161 Lenck Oct 1987 A
4731052 Seitz, Jr. Mar 1988 A
4805628 Fry et al. Feb 1989 A
4809860 Allen Mar 1989 A
4810244 Allen Mar 1989 A
4824434 Seitz, Jr. Apr 1989 A
4832681 Lenck May 1989 A
4869259 Elkins Sep 1989 A
4874649 Daubenbüchel et al. Oct 1989 A
4877033 Seitz, Jr. Oct 1989 A
4877615 Taylor Dec 1989 A
5048530 Hurwitz Sep 1991 A
5071425 Gifford, III et al. Dec 1991 A
5081997 Bosley, Jr. et al. Jan 1992 A
5090414 Takano Feb 1992 A
5149328 Zaha Sep 1992 A
5160319 Emery et al. Nov 1992 A
5195979 Schinkel et al. Mar 1993 A
5201314 Bosley et al. Apr 1993 A
5211627 William May 1993 A
5250649 Onwumere et al. Oct 1993 A
5259837 Van Wormer Nov 1993 A
5273527 Schatz et al. Dec 1993 A
5289831 Bosley Mar 1994 A
5327891 Rammler Jul 1994 A
5342309 Hausser Aug 1994 A
5360389 Chenette Nov 1994 A
5383466 Partika Jan 1995 A
5405321 Reeves Apr 1995 A
5415634 Glynn et al. May 1995 A
5468221 Schoner Nov 1995 A
5596990 Yock et al. Jan 1997 A
5611345 Hibbeln Mar 1997 A
5622665 Wang Apr 1997 A
5646194 Kobayashi et al. Jul 1997 A
5688490 Tournier et al. Nov 1997 A
5724977 Yock et al. Mar 1998 A
5741522 Violante et al. Apr 1998 A
5744092 Halgren et al. Apr 1998 A
5759154 Hoyns Jun 1998 A
5766135 Terwilliger Jun 1998 A
5769795 Terwilliger Jun 1998 A
5772642 Ciamacco, Jr. et al. Jun 1998 A
5820554 Davis et al. Oct 1998 A
5820850 Hashimoto et al. Oct 1998 A
5827174 Reuss, Jr. et al. Oct 1998 A
5843023 Cecchi Dec 1998 A
5851464 Davila et al. Dec 1998 A
5851477 Halgren et al. Dec 1998 A
5879305 Yock et al. Mar 1999 A
5921933 Sarkis Jul 1999 A
5932154 Csongor et al. Aug 1999 A
5932299 Katoot Aug 1999 A
5939015 Csongor Aug 1999 A
5945061 Csongor et al. Aug 1999 A
5967988 Briscoe et al. Oct 1999 A
5976501 Jablonski Nov 1999 A
6010448 Thompson Jan 2000 A
6018676 Davis et al. Jan 2000 A
6024727 Thorne et al. Feb 2000 A
6027443 Nag Feb 2000 A
6030369 Engelson Feb 2000 A
6063221 Weinberg et al. May 2000 A
6071580 Bland et al. Jun 2000 A
6074578 Csongor et al. Jun 2000 A
6086540 Bonneville et al. Jul 2000 A
6106473 Violante et al. Aug 2000 A
6110444 Klaveness et al. Aug 2000 A
6165165 Cecchi Dec 2000 A
6207752 Abraham et al. Mar 2001 B1
6210330 Tepper Apr 2001 B1
6240960 Fillmore Jun 2001 B1
6261241 Burbank et al. Jul 2001 B1
6277084 Abele et al. Aug 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6290672 Abae Sep 2001 B1
6306094 Joseph Oct 2001 B1
6312429 Burbank et al. Nov 2001 B1
6331166 Burbank et al. Dec 2001 B1
6344026 Burbank et al. Feb 2002 B1
6346086 Maksem et al. Feb 2002 B1
6347241 Burbank et al. Feb 2002 B2
6356782 Sirimanne et al. Mar 2002 B1
6358211 Mamayek Mar 2002 B1
6364855 Zappala Apr 2002 B1
6371904 Sirimanne et al. Apr 2002 B1
6371973 Tepper Apr 2002 B1
6427081 Burbank et al. Jul 2002 B1
6432352 Csongor Aug 2002 B1
6435189 Lewis et al. Aug 2002 B1
6454727 Burbank et al. Sep 2002 B1
6461302 Thompson Oct 2002 B1
6471700 Burbank et al. Oct 2002 B1
6481462 Fillmore et al. Nov 2002 B2
6497706 Burbank et al. Dec 2002 B1
6506156 Jones et al. Jan 2003 B1
6517498 Burbank et al. Feb 2003 B1
6527752 Bosley, Jr. et al. Mar 2003 B1
6540693 Burbank et al. Apr 2003 B2
6540695 Burbank et al. Apr 2003 B1
6544185 Montegrande Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6567689 Burbank et al. May 2003 B2
6508773 Burbank et al. Jun 2003 B2
6577904 Zhang et al. Jun 2003 B1
6610005 Tao Aug 2003 B1
6610016 Violante et al. Aug 2003 B1
6638234 Burbank et al. Oct 2003 B2
6656407 Halgren et al. Dec 2003 B1
6659105 Burbank et al. Dec 2003 B2
6662041 Burbank et al. Dec 2003 B2
6673440 Douglas et al. Jan 2004 B2
6676658 Burbank et al. Jan 2004 B2
6679824 Reed et al. Jan 2004 B1
6679851 Burbank et al. Jan 2004 B2
6685648 Flaherty et al. Feb 2004 B2
6689071 Burbank et al. Feb 2004 B2
6695767 Martinez Garcia et al. Feb 2004 B2
6695787 Hogendijk et al. Feb 2004 B2
6699206 Burbank et al. Mar 2004 B2
6712775 Burbank et al. Mar 2004 B2
6716179 Burbank et al. Apr 2004 B2
6723052 Mills Apr 2004 B2
6725083 Burbank et al. Apr 2004 B1
6736409 Hollenberg May 2004 B2
6749554 Snow et al. Jun 2004 B1
6758848 Burbank et al. Jul 2004 B2
6761680 Terwilliger et al. Jul 2004 B2
6786858 Terwilliger et al. Sep 2004 B2
6838278 Fortino Jan 2005 B2
6840090 Smith Jan 2005 B2
6860856 Ward et al. Mar 2005 B2
6862470 Burbank et al. Mar 2005 B2
6875168 Bateman et al. Apr 2005 B2
6875182 Wardle et al. Apr 2005 B2
6905458 Choay et al. Jun 2005 B2
6958044 Burbank et al. Oct 2005 B2
6993375 Burbank et al. Jan 2006 B2
6996433 Burbank et al. Feb 2006 B2
6997885 Lubock et al. Feb 2006 B2
7014610 Koulik Mar 2006 B2
7047063 Burbank et al. May 2006 B2
7060020 Terwilliger et al. Jun 2006 B2
7188537 Junger Mar 2007 B2
7189206 Quick et al. Mar 2007 B2
7229413 Violante et al. Jun 2007 B2
7229418 Burbank et al. Jun 2007 B2
7229439 Burbank et al. Jun 2007 B2
7235052 Kellar et al. Jun 2007 B2
7258669 Russell Aug 2007 B2
7261712 Burbank et al. Aug 2007 B2
7264596 Burbank et al. Sep 2007 B2
7282034 Burbank et al. Oct 2007 B2
7322938 Burbank et al. Jan 2008 B2
7322939 Burbank et al. Jan 2008 B2
7322940 Burbank et al. Jan 2008 B2
7329228 Burbank et al. Feb 2008 B2
7357794 Makower et al. Apr 2008 B2
7357801 Burbank et al. Apr 2008 B2
7377902 Burbank et al. May 2008 B2
7382857 Engel Jun 2008 B2
7384391 Spittle et al. Jun 2008 B2
7470249 Junger Dec 2008 B2
7488295 Burbank et al. Feb 2009 B2
7565191 Burbank et al. Jul 2009 B2
7625347 Burbank et al. Dec 2009 B2
7637904 Wingler et al. Dec 2009 B2
7651467 Lubock et al. Jan 2010 B2
7651505 Lubock et al. Jan 2010 B2
7668582 Sirimanne et al. Feb 2010 B2
7736337 Diep et al. Jun 2010 B2
7792569 Burbank et al. Sep 2010 B2
7794402 Wang Sep 2010 B2
7819819 Quick et al. Oct 2010 B2
7867169 Webler et al. Jan 2011 B2
7879011 Chang Feb 2011 B2
7887737 Mejlhede et al. Feb 2011 B2
7970454 Jones et al. Jun 2011 B2
7983734 Jones et al. Jul 2011 B2
8052669 Lee-Sepsick et al. Nov 2011 B2
8092390 Field Jan 2012 B2
8137346 Burbank et al. Mar 2012 B2
8147487 Burbank et al. Apr 2012 B2
8152737 Burbank et al. Apr 2012 B2
8177792 Lubock et al. May 2012 B2
8200313 Rambod et al. Jun 2012 B1
8219182 Burbank et al. Jul 2012 B2
8224424 Burbank et al. Jul 2012 B2
8229553 Burbank et al. Jul 2012 B2
8273009 Arabia et al. Sep 2012 B2
8282573 Shabaz et al. Oct 2012 B2
8303509 Webler et al. Nov 2012 B2
8306602 Sirimanne et al. Nov 2012 B2
8320993 Sirimanne et al. Nov 2012 B2
8320994 Sirimanne et al. Nov 2012 B2
8343071 Shabaz et al. Jan 2013 B2
8360990 Shabaz et al. Jan 2013 B2
8361082 Jones et al. Jan 2013 B2
8377109 Vrba et al. Feb 2013 B2
8382674 Webler Feb 2013 B2
8398596 Field Mar 2013 B2
8430863 Webler Apr 2013 B2
8460204 Quick et al. Jun 2013 B2
8465412 Kamrava Jun 2013 B2
8498693 Jones et al. Jul 2013 B2
8560052 Mills Oct 2013 B2
8585596 Flaherty et al. Nov 2013 B1
8600481 Sirimanne et al. Dec 2013 B2
8603121 Surti et al. Dec 2013 B2
8622887 Gergeley Jan 2014 B2
8626269 Jones et al. Jan 2014 B2
8626270 Burbank et al. Jan 2014 B2
8633023 Du et al. Jan 2014 B2
8636734 Burbank et al. Jan 2014 B2
8656928 Carlson et al. Feb 2014 B2
8663116 Hamilton, Jr. Mar 2014 B2
8672892 Carr et al. Mar 2014 B2
8690752 Jose Apr 2014 B2
8718745 Burbank et al. May 2014 B2
8784433 Lubock et al. Jul 2014 B2
8795452 Alpert et al. Aug 2014 B2
8834370 Evert et al. Sep 2014 B2
8880154 Jones et al. Nov 2014 B2
8936553 Stigall et al. Jan 2015 B2
8951195 Sheldon et al. Feb 2015 B2
8959753 Garbini et al. Feb 2015 B2
8965486 Burbank et al. Feb 2015 B2
9033889 Hamilton, Jr. May 2015 B2
9034363 Doshi et al. May 2015 B2
9044162 Jones et al. Jun 2015 B2
9044215 Shabaz et al. Jun 2015 B2
9085097 Lentz et al. Jul 2015 B2
9107640 Ho et al. Aug 2015 B2
9149341 Jones et al. Oct 2015 B2
9179935 Zarnescu et al. Nov 2015 B2
9204866 Shabaz et al. Dec 2015 B2
9216012 Burbank et al. Dec 2015 B2
9216037 Buster et al. Dec 2015 B2
9220880 Lee-Sepsick et al. Dec 2015 B2
9237937 Burbank et al. Jan 2016 B2
9242076 Burton et al. Jan 2016 B2
9247960 Carson et al. Feb 2016 B2
9320540 Badie Apr 2016 B2
9636082 Field May 2017 B2
9642591 Field et al. May 2017 B2
20020026117 Joseph Feb 2002 A1
20020134850 Hollenberg Sep 2002 A1
20020177776 Crawford Keller et al. Nov 2002 A1
20030032896 Bosley, Jr. Feb 2003 A1
20030040756 Field Feb 2003 A1
20030050531 Field Mar 2003 A1
20030206864 Mangin Nov 2003 A1
20030208101 Cecchi Nov 2003 A1
20040230119 Brustad et al. Nov 2004 A1
20050074406 Couvillon, Jr. et al. Apr 2005 A1
20050143656 Burbank et al. Jun 2005 A1
20060089608 Shaykh et al. Apr 2006 A1
20060095015 Hobbs et al. May 2006 A1
20060106338 Chang May 2006 A1
20070167822 Webler et al. Jul 2007 A1
20070179575 Esch et al. Aug 2007 A1
20070255140 Violante et al. Nov 2007 A1
20070265516 Wang Nov 2007 A1
20080058702 Arndt et al. Mar 2008 A1
20080154136 Webler Jun 2008 A1
20100256577 Field Oct 2010 A1
20100331955 Vrba et al. Dec 2010 A1
20130281835 Field et al. Oct 2013 A1
Foreign Referenced Citations (104)
Number Date Country
38 33 365 Apr 1989 DE
39 36 162 Jun 1991 DE
40 14 998 Nov 1991 DE
299 08 256 Jul 1999 DE
197 27 740 Sep 1999 DE
0 033 659 Aug 1981 EP
0 072 671 Feb 1983 EP
0 083 973 Jul 1983 EP
0 109 657 May 1984 EP
0 131 166 Jan 1985 EP
0 243 341 Oct 1987 EP
0 323 527 Jul 1989 EP
0 356 774 Mar 1990 EP
0 382 392 Aug 1990 EP
0 386 936 Sep 1990 EP
0 481 685 Apr 1992 EP
0 526 669 Feb 1993 EP
0 552 924 Jul 1993 EP
0 567 285 Oct 1993 EP
0 586 056 Mar 1994 EP
0 624 342 Nov 1994 EP
0 701 836 Mar 1996 EP
0 935 442 Aug 1999 EP
0 941 128 Sep 1999 EP
0 995 459 Apr 2000 EP
0 996 363 May 2000 EP
1 105 170 Jun 2001 EP
1 109 496 Jun 2001 EP
1 132 049 Sep 2001 EP
1 139 878 Oct 2001 EP
1 146 910 Oct 2001 EP
1 152 696 Nov 2001 EP
1 155 418 Nov 2001 EP
1 118 337 Jan 2002 EP
1 166 720 Jan 2002 EP
1 173 096 Jan 2002 EP
1 177 776 Feb 2002 EP
1 189 546 Mar 2002 EP
1 196 107 Apr 2002 EP
1 274 353 Jan 2003 EP
1 358 856 Nov 2003 EP
1 450 891 Sep 2004 EP
0 941 128 Oct 2004 EP
1 491 147 Dec 2004 EP
1 494 721 Jan 2005 EP
1 513 581 Mar 2005 EP
1 525 856 Apr 2005 EP
1 599 125 Nov 2005 EP
1 626 667 Feb 2006 EP
1 667 589 Jun 2006 EP
1 696 800 Sep 2006 EP
1 781 178 May 2007 EP
1 919 388 May 2008 EP
1 967 147 Sep 2008 EP
2 103 266 Sep 2009 EP
2 114 270 Nov 2009 EP
2 174 596 Apr 2010 EP
2 319 449 May 2011 EP
2 389 868 Nov 2011 EP
2 407 111 Jan 2012 EP
2 407 119 Jan 2012 EP
2 517 630 Oct 2012 EP
2 555 687 Feb 2013 EP
2 564 890 Mar 2013 EP
2 570 150 Mar 2013 EP
2 620 111 Jul 2013 EP
2 641 546 Sep 2013 EP
2 984 991 Feb 2016 EP
2 995 260 Mar 2016 EP
2 716 266 Aug 1995 FR
829383 Mar 1960 GB
894653 Apr 1962 GB
1.151222 May 1969 GB
2 263 642 Aug 1995 GB
2 274 991 Oct 1996 GB
2 379 610 Mar 2003 GB
2 381 198 Apr 2003 GB
2 388 784 Nov 2003 GB
2 380 944 Oct 2004 GB
2 379 610 Jan 2005 GB
2494395 Jan 2014 GB
2494864 Feb 2014 GB
2469839 Sep 2014 GB
S 53-66986 Jun 1978 JP
55-125876 Sep 1980 JP
58-92951 Jun 1983 JP
58-198353 Nov 1983 JP
3-14451 Feb 1991 JP
06-327671 Nov 1994 JP
8-173543 Jul 1996 JP
H 09-123302 May 1997 JP
2844238 Jan 1999 JP
2001-504101 Mar 2001 JP
2002-106759 Apr 2002 JP
2002-234066 Aug 2002 JP
2003-190275 Jul 2003 JP
1255450 Sep 1986 SU
WO 9417743 Aug 1994 WO
WO 9523615 Sep 1995 WO
9819713 May 1998 WO
WO 9903399 Jan 1999 WO
0009178 Feb 2000 WO
WO 200113021 Feb 2001 WO
WO 0202171 Jan 2002 WO
Non-Patent Literature Citations (6)
Entry
Demand for Invalidation Trial to the Commissioner of the Japan Patent Office re Appeal Case for Invalidating JP Patent No. 4724372 dated Jan. 28, 2019.
Coloreu, B. et al., “Embryo transfer under ultrasound guidance improves pregnancy rates after in-vitro fertilization”, Human Reproduction, vol. 15, No. 3, pp. 616-620 (2000).
Hale, Lyndon, “Embryo transfer: how to ensure correct placement in utero”, Reproduction, Fertility and Development, vol. 13, pp. 95-98 (2001).
Strickler, Ronald C. et al., “Ultrasound guidance for human embryo transfer”, Fertility and Sterility, vol. 43, No. 1, pp. 54-61 (Jan. 1985).
Wood, Ellen G. et al., “Ultrasound-guided soft catheter embryo transfers will improve pregnancy rates in in-vitro fertilization”, Human Reproduction, vol. 15, No. 1, pp. 107-112 (2000).
Woolcott, Robert et al., “Potentially important variables identified by transvaginal ultrasound-guided embryo transfer”, Human Reproduction, vol. 12, No. 5, pp. 963-966 (1997).
Related Publications (1)
Number Date Country
20130281835 A1 Oct 2013 US
Continuations (1)
Number Date Country
Parent 10803882 Mar 2004 US
Child 13914684 US